ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
25 announcements with these filters
Crescentis Capital Ltd intimated BSE of a board meeting on 12 November 2026 to approve Q2 and half-year unaudited results. It also notes the trading window stays closed until 48 hours after results.
Crescentis Capital's board approved the Letter of Offer for a rights issue of 1,02,08,129 shares at Rs.78 each. The issue aggregates to Rs.7,962.34 lakhs, or about Rs.79.62 Crore, assuming full subscription.
Crescentis Capital approved Rights Issue terms: 1,02,08,129 shares at ₹78, raising ₹79.62 Crore. Record date November 4; issue closes November 27, 2026.
Crescentis Capital will hold a Fund-Raising Committee meeting on 29 October 2026 to approve the terms of a proposed rights issue of up to Rs 80 crore. The filing is a prior intimation of that committee meeting.
Crescentis Capital Limited submitted the Reconciliation of Share Capital Audit Report for the quarter ended September 30, 2026, as per SEBI regulations.
Crescentis Capital Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Crescentis Capital Limited granted 5,00,000 stock options to its Managing Director, Mr. Subba Rao Veeravenkata Meka, under the company's 2025 ESOS scheme.
Crescentis Capital Limited's board has approved a rights issue of equity shares for up to Rs 80 Crore. The board also approved the Draft Letter of Offer.
Crescentis Capital will hold a board meeting on September 29, 2026, to discuss progress on its proposed rights issue of equity shares.
Crescentis Capital Limited conducted its 33rd Annual General Meeting on August 26, 2026. The meeting transacted key business, including director reappointments and ESOP plan approvals.
Crescentis Capital Ltd reported revenue from operations of ₹10.9 Cr (+118.0% YoY) and net profit of ₹7.8 Cr (+129.4% YoY) for Q1 FY27.
Crescentis Capital Limited will hold a board meeting on 13th August, 2026, to consider and approve the unaudited financial results for the quarter ended 30th June, 2026.
Crescentis Capital Limited scheduled its 33rd Annual General Meeting for August 26, 2026. The meeting will address financial statements and the re-appointment of directors.
Crescentis Capital Limited submitted its Reconciliation of Share Capital Audit Report for the quarter ended June 30, 2026. This filing confirms compliance with SEBI Regulation 76.
Mr. Sai Kumar Subramanya resigned as Head – Business Development (AVP) of Crescentis Capital Limited. The resignation is effective from July 16, 2026.
Crescentis Capital Ltd filed its quarterly shareholding pattern as of 30 June 2026, detailing holdings across promoters, public and institutions. No financial or capital changes were disclosed.
Dr. Bhaskara Rao Bollineni gifted 3,00,000 shares to Mr. Bhavanam Ruthvik Reddy. This inter-se transfer represents 1.76% of the company's paid-up equity capital.
Crescentis Capital Limited submitted a corrected declaration regarding its unmodified audit opinion for FY26 results. The filing fixes a previous clerical error in regulatory reporting.
Crescentis Capital re-appointed Mr. Subba Rao Meka as MD and Mr. Bhavanam Reddy as CEO for five-year terms. These leadership continuities support long-term strategic execution.
Crescentis Capital Limited granted 5,00,000 stock options to its Managing Director at Rs. 50 each. Totaling ₹2.50 Crore, the options vest over two years.
Crescentis Capital Limited submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report indicates no material non-compliance or deviations.
Crescentis Capital Ltd reported revenue from operations of -₹7.4 Cr and a net loss of ₹7.4 Cr for Q4 FY26.
Crescentis Capital approved audited FY26 financial results and a ₹80 Crore rights issue. The fundraise aims to strengthen the company's capital base.
Crescentis Capital Limited scheduled a board meeting for May 29, 2026, to approve annual financial results and explore fund-raising options. Trading window remains closed.
Crescentis Capital Limited rebranded its corporate identity and filed trademark applications for its new logo. This follows its formal name change effective January 2026.